Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE PSP94 serum measurements, especially of bound and free forms, have potential clinical utility in prostate cancer management. 15344909

2005

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE MSMB has potential as a biomarker of prostate cancer development, progression and recurrence and potentially as a target for therapeutic intervention. 19790236

2010

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE MSMB levels are also reduced in the circulation and MSMB is therefore used as a serum biomarker for prostate cancer. 29250809

2018

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE PSP94 is a potential biomarker for evaluating patients with prostate carcinoma. 9136076

1997

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE PSP94 has shown potential to be a serum biomarker for evaluating prostate cancer. 9136077

1997

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Prostate secretory protein of 94 amino acids (PSP94) has shown the potential to be a diagnostic biomarker and a therapeutic agent for prostate cancer. 9174167

1997

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE rs10993994 in MSMB promoter affects serum MSMB expression, contributes to the genetic predisposition to prostate cancer in southern Chinese Han population. 20333697

2010

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation GWASCAT A genome-wide association study of prostate cancer in Latinos. 31226226

2020

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE A peak at m/z 10,760 was identified as β-microseminoprotein (β-MSMB) and found to be statistically lower in urine from PCa participants using the peak's average areas. 24115268

2014

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE A plausible functional basis for a few loci, such as FGFR2 for breast cancer and MSMB for prostate cancer, has been elucidated, but the majority are not understood and suggest new mechanisms of carcinogenesis. 20418093

2010

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE A total of 31 proteins were associated with prostate cancer risk including proteins encoded by <i>GSTP1</i>, whose methylation level was shown previously to be associated with prostate cancer risk, and <i>MSMB, SPINT2, IGF2R</i>, and <i>CTSS</i>, which were previously implicated as potential target genes of prostate cancer risk variants identified in genome-wide association studies. 31337649

2019

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Across 66 meta-analyses, a total of 20 genetic variants involving 584,100 subjects in 19 different genes (KLK3, IGFBP3, ESR1, SOD2, CAT, CYP1B1, VDR, RFX6, HNF1B, SRD5A2, FGFR4, LEP, HOXB13, FAS, FOXP4, SLC22A3, LMTK2, EHBP1 and MSMB) exhibited significant association with prostate cancer. 26967244

2016

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE Additional copies of the prostate cancer risk allele resulted in lower beta-MSP but higher PSA levels, and singly explained 23% and 5% of the variation seen in semen beta-MSP and PSA, respectively. 20696662

2010

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Additionally, 6 pathways were identified based on identified variants and genes, including estrogen signaling pathway, signaling by MST1, IL-15 production, MSP-RON signaling pathway, and IL-12 signaling and production in macrophages, which are known to be associated with prostate cancer. 31748686

2019

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Another novel mechanism, which we propose in this review article, is that PSP94 may protect against prostate cancer by preventing or limiting an intracellular fungal infection in the prostate. 24464504

2014

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure. 23608167

2013

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer. 23484134

2013

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 AlteredExpression BEFREE Decreased expression of prostatic secretory protein PSP94 in prostate cancer. 7506990

1993

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. 20680031

2010

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. 19383797

2009

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 GeneticVariation BEFREE For the two SNPs that had significant differences between more and less aggressive disease rs2735839 in KLK3 (P = 8.4 x 10(-7)) and rs10993994 in MSMB (P = 0.046), the alleles that are associated with increased risk for PCa were more frequent in patients with less aggressive disease. 19434657

2009

Entrez Id: 4477
Gene Symbol: MSMB
MSMB
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.200 Biomarker BEFREE Further improvement was achieved by multivariate logistic regression analysis, which identified novel duplex (TRPM8 and MSMB), triplex (plus AMACR) and quadriplex (plus PCA3) models for the detection of early CaPs (AUC=0.665, 0.726 and 0.741, respectively). 21788966

2011